Last updated on July 2010

Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Polycystic Ovary Syndrome
  • Age: Between 18 - 38 Years
  • Gender: Female
  • Other:
    All patients with polycystic ovarian syndrome will be invited to participate in the
    tudy. The PCOS criteria are according to modified Rotterdam criteria (7); i.e.,
    oligoovulation defined as < 6 menstrual periods per year, signs of clinical
    hyperandrogenism (Ferriman and Gallwey >8) or laboratorial (total Testosterone >=0.81
    ng/dL) or polycystic ovary > 10cm3.
    Furthermore, all patients with infertility diagnosis based solely on ovulation factor will
    included in the protocol
    Age >18 years old and <= 38 years old.
    No endometriosis on laparoscopy

You may not be eligible for this study if the following are true:

  • Not willing to participate in the study
    use of IUD or contraceptive pill within 2 months before the study.
    Hyperprolactinemia (>20ng/mL)
    Abnormal serum levels of TSH(normal range:0.4-40 mUI/mL).
    High 17-OH progesterone (>=4.9ng/mL)
    Known allergy to clomiphene or raloxifene

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.